<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30057195</PMID>        <DateRevised>            <Year>2018</Year>            <Month>07</Month>            <Day>30</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1878-4046</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Jul</Month>                        <Day>26</Day>                    </PubDate>                </JournalIssue>                <Title>Academic radiology</Title>                <ISOAbbreviation>Acad Radiol</ISOAbbreviation>            </Journal>            <ArticleTitle>Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S1076-6332(18)30310-6</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.acra.2018.05.026</ELocationID>            <Abstract>                <AbstractText Label="RATIONALE AND OBJECTIVES" NlmCategory="OBJECTIVE">To compare outcomes associated with breast cancer screening with digital mammography (DM) alone versus in combination with digital breast tomosynthesis (DBT) in a large representative cohort.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A total of 325,729 screening mammograms from 247,431 women were analyzed, across two healthcare systems, from June 2015 to September 2017. Patient level demographic, calculated risk levels, and clinical outcomes were extracted from radiology information system and electronic medical records. Multivariable regression modeling adjusting for institution, age, breast density, and first exam was conducted to compare patient characteristics, recall rates, time to biopsy and final diagnosis, clinical outcomes, and diagnostic performance. Participating institutions and the Coordinating Center received Institutional Review Board approval for a waiver of consent to collect and link data and perform analysis.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 194,437 (59.7%) screens were DBT versus 131,292 (40.3%) with DM. Women with dense breasts and higher calculated risk were more likely to be screened with DBT. Recall rates were lower for DBT overall (8.83% DBT vs 10.98% DM, adjusted odds ratio, 95% confidence interval = 0.85, 0.83-0.87) and across all age groups, races, and breast densities, and at facilities that used predominantly DBT (8.05%) versus predominantly DM (11.22%), or a combination (10.73%). The most common diagnostic pathway after recall was mammography and ultrasound. Women recalled from DBT were more likely to proceed directly to ultrasound. The median time to biopsy (18 vs 22 days) and final diagnosis (10 vs 13 days) was shorter for DBT. The adjusted cancer rate, cancer detection rate, and specificity were higher for DBT.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">DBT demonstrated a more efficient screening pathway and improved quality measures with lower recall rates in all patient types, reduced diagnostic mammography and shorter time to biopsy and final diagnosis.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Alsheik</LastName>                    <ForeName>Nila H</ForeName>                    <Initials>NH</Initials>                    <AffiliationInfo>                        <Affiliation>Advocate Caldwell Breast Center, Advocate Lutheran General Hospital, 1700 Luther Lane, Park Ridge, IL.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dabbous</LastName>                    <ForeName>Firas</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>James R. &amp; Helen D. Russell Institute for Research &amp; Innovation, Advocate Lutheran General Hospital-Center for Advanced Care, 1700 Luther Lane, Suite 1410, Park Ridge, IL 60068.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pohlman</LastName>                    <ForeName>Scott K</ForeName>                    <Initials>SK</Initials>                    <AffiliationInfo>                        <Affiliation>Hologic Inc., 250 Campus Drive, Marlborough, MA 01752.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Troeger</LastName>                    <ForeName>Kathleen M</ForeName>                    <Initials>KM</Initials>                    <AffiliationInfo>                        <Affiliation>Hologic Inc., 250 Campus Drive, Marlborough, MA 01752.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gliklich</LastName>                    <ForeName>Richard E</ForeName>                    <Initials>RE</Initials>                    <AffiliationInfo>                        <Affiliation>OM1 Inc., 800 Boylston Street, Suite 1410, Boston, MA 02199.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Donadio</LastName>                    <ForeName>Gregory M</ForeName>                    <Initials>GM</Initials>                    <AffiliationInfo>                        <Affiliation>OM1 Inc., 800 Boylston Street, Suite 1410, Boston, MA 02199.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Su</LastName>                    <ForeName>Zhaohui</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>OM1 Inc., 800 Boylston Street, Suite 1410, Boston, MA 02199.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Menon</LastName>                    <ForeName>Vandana</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>OM1 Inc., 800 Boylston Street, Suite 1410, Boston, MA 02199.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Conant</LastName>                    <ForeName>Emily F</ForeName>                    <Initials>EF</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, 3400 Spruce Street, Hospital of the University of Pennsylvania, Philadelphia, PA 19104. Electronic address: emily.conant@uphs.upenn.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>26</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Acad Radiol</MedlineTA>            <NlmUniqueID>9440159</NlmUniqueID>            <ISSNLinking>1076-6332</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Cancer detection</Keyword>            <Keyword MajorTopicYN="N">Recall</Keyword>            <Keyword MajorTopicYN="N">Tomosynthesis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>05</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30057195</ArticleId>            <ArticleId IdType="pii">S1076-6332(18)30310-6</ArticleId>            <ArticleId IdType="doi">10.1016/j.acra.2018.05.026</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>